Appreciation for Interconnectedness
It was March 2020 when I wrote the first sentences of issue #30 of this e-conversation. At the time, I acknowledged the WHO’s declaration that COVID-19 had reached the threshold of a global pandemic.
Finding Partners in Biopharma: Standing Out in a Field of Many
When biopharma executives or business development leaders think about developing their “partnering story,” the focus is often on the innovation. That’s understandable. These are science-based organizations, and without question, the innovation is fundamental to the work.
Gaining Participation in Clinical Trials
When it comes to patient recruitment and retention for clinical trials, the bottom line is simply this: It is important and challenging in all scenarios… the difference is in how significant the focus and effort will need to be.
Reboot the “Get Organized” Ideas
Last week, The NemetzGroup team met (virtually, of course!) to share insights from 2021 and how we could make 2022 even better. We broke into small Zoom groups, each of which was given 10 minutes to brainstorm on four topics:
Freedom to Lead
In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to Lead” would resonate with our audience of early- to mid-stage biopharma companies.